Softwr

Healthcare · head to head

DHIS2 vs Fullscript

DHIS2 logo

DHIS2

Healthcare

Open source health information platform run from the University of Oslo and used by national ministries

From
Free
Rated
-
Fullscript logo

Fullscript

Healthcare

Supplement dispensing for practitioners, free to use because it earns on the products

From
Free
Rated
-

The short version

  • Each has a real cost: DHIS2 the licence is free and the implementation is not; national rollouts routinely cost hundreds of thousands of dollars in configuration, hosting, training and support, and budgets built on the word free fail immediately.; Fullscript the practitioner sets their own margin on products they clinically recommend, which is a conflict of interest that some professional bodies and patients view badly, and the platform makes the arrangement easy rather than making it visible.
  • They diverge on capability: DHIS2 covers Aggregate data reporting, Fullscript covers Protocol dispensing.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which DHIS2 and Fullscript actually diverge.

Attributes where DHIS2 and Fullscript differ
AttributeDHIS2Fullscript
Pricing modelOpen source, no licence feePer user per month
PlatformsWeb, Android, Self-hosted, CloudWeb, iOS, Android

Identical on both: starting price (Free), free tier (Yes), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in DHIS2

  • Aggregate data reporting
  • Tracker
  • Android capture app
  • Dashboards and analytics
  • Metadata packages
  • Data quality tools
  • GIS mapping
  • Interoperability

Only in Fullscript

  • Protocol dispensing
  • Profit dispensary
  • Auto refill
  • Lab ordering
  • Patient app
  • EHR integration
  • Enterprise catalogue control

What people use each for

The jobs each tool is most often brought in to do.

DHIS2

  • A ministry of health replacing paper monthly reporting from thousands of facilities with a national routine systemnot Fullscript
  • A donor-funded HIV or tuberculosis programme that must report standard indicators across several districtsnot Fullscript
  • A disease surveillance unit needing weekly case reporting with outbreak alerting and mappingnot Fullscript
  • An NGO running individual patient follow-up in a programme where facilities are frequently offlinenot Fullscript

Fullscript

  • A functional medicine practice that wants to stop holding supplement stock, cash and expiry risk in the clinicnot DHIS2
  • A dietitian or naturopath adding a dispensary revenue stream without buying inventory upfrontnot DHIS2
  • A clinic that needs patients to actually keep taking a protocol, where auto refills and dose reminders address the adherence problem directlynot DHIS2
  • A multi site integrative health group that wants a single approved catalogue rather than each clinician choosing their own brandsnot DHIS2

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

DHIS2

  • The licence is free and the implementation is not; national rollouts routinely cost hundreds of thousands of dollars in configuration, hosting, training and support, and budgets built on the word free fail immediately.
  • HISP UiO introduced a Shared Services Fee in 2025, so organisations that depend on DHIS2 are now being asked for an annual contribution that did not previously exist in their plans.
  • Development funding comes from a small set of donors including Norad, the Global Fund and the Gates Foundation, which concentrates the platform's long-term direction in the priorities of those funders.
  • Implementation capability is concentrated in regional HISP groups, so a country whose local HISP group is overstretched has few alternative suppliers with equivalent expertise.
  • Analytics performance depends heavily on how metadata was designed at the outset, and a poorly structured initial configuration produces slow dashboards and bad indicator definitions that are painful to correct years later.

Fullscript

  • The practitioner sets their own margin on products they clinically recommend, which is a conflict of interest that some professional bodies and patients view badly, and the platform makes the arrangement easy rather than making it visible.
  • The account is free but the practice does not control pricing, catalogue, shipping cost or the patient discount, so the entire economics of the dispensary can be changed by the vendor without the practice having any lever.
  • Converting to a profit account requires personal identity verification, tax details and a bank account, and makes dispensary earnings the practitioner personal taxable income to report, which is administrative work no one warns about at signup.
  • Product availability and shipping are geographically limited, so practices outside the supported countries cannot use it at all and cross border patients will find items unavailable at checkout.
  • Patient refill schedules, plan history and a slice of practice revenue accumulate inside a platform the practice cannot export in a form another dispensary would accept, so switching later means asking every patient to re-enrol somewhere else.

Pricing, plan by plan

DHIS2

Free
  • DHIS2 softwareFree
    • BSD licence
    • All modules including Tracker
    • No user or facility limits
  • Shared Services Fee$undefined/year
    • Voluntary annual contribution introduced by HISP UiO
    • Funds shared global infrastructure and platform sustainability
    • Amount agreed with the HISP Centre
  • Implementation and support$undefined/year
    • Delivered by regional HISP groups or private implementers
    • Configuration, metadata design, hosting, training and support
    • Quoted per programme, commonly the dominant cost

Fullscript

Free
  • PractitionerFree
    • Full catalogue and dispensing at no account fee
    • Lab ordering and results
    • Standard EHR integrations
  • PatientFree
    • No account fee
    • Mobile app with dose reminders
    • Auto refills, cancellable at any time
  • Enterprise$undefined/year
    • Quoted for health systems and multi site groups
    • Centrally managed catalogue with quality standards
    • API level EHR integration

Which should you pick?

Choose DHIS2 if

  • You need aggregate data reporting.
  • You want to start without paying.
  • You work on Web, Android, Self-hosted, Cloud.
  • You also want tracker.

Choose Fullscript if

  • You need protocol dispensing.
  • You want to start without paying.
  • You work on Web, iOS, Android.
  • You also want profit dispensary.

Questions people ask

Is DHIS2 or Fullscript better?
Neither clearly leads. DHIS2 starts at Free and Fullscript at Free, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, DHIS2 or Fullscript?
DHIS2 starts at Free and Fullscript at Free.
Does DHIS2 or Fullscript run on more platforms?
DHIS2 runs on Web, Android, Self-hosted, Cloud. Fullscript runs on Web, iOS, Android.
Can I use DHIS2 for free?
Both have a free tier, so you can try either at no cost before committing.
What is DHIS2 best used for?
DHIS2 is most often used for a ministry of health replacing paper monthly reporting from thousands of facilities with a national routine system, a donor-funded hiv or tuberculosis programme that must report standard indicators across several districts, a disease surveillance unit needing weekly case reporting with outbreak alerting and mapping, an ngo running individual patient follow-up in a programme where facilities are frequently offline. Of those, a ministry of health replacing paper monthly reporting from thousands of facilities with a national routine system and a donor-funded hiv or tuberculosis programme that must report standard indicators across several districts are not what Fullscript is typically brought in for.
What can DHIS2 do that Fullscript cannot?
DHIS2 covers Aggregate data reporting, Tracker, Android capture app, Dashboards and analytics. Fullscript covers Protocol dispensing, Profit dispensary, Auto refill, Lab ordering.

Answered from the vendors’ own pages

DHIS2: Who owns and develops DHIS2?

The HISP Centre at the University of Oslo, funded by donors including Norad, the Global Fund, the Gates Foundation and Wellcome.

Fullscript: Is Fullscript really free for practitioners?

Yes, the account has no fee. Fullscript earns on the supplements sold through it, and a practitioner on a profit account also earns a margin on those sales.

DHIS2: Is DHIS2 free?

The software is free under a BSD licence. Implementation, hosting, training and support are not, and are the dominant cost.

Fullscript: How do practitioners make money on it?

By converting to a profit dispensary and setting a margin. That requires tax information and a bank account, and the earnings are taxable income.

DHIS2: What is the Shared Services Fee?

A voluntary annual contribution introduced by HISP UiO in 2025 to fund shared global infrastructure and long-term platform sustainability.

Fullscript: What do patients pay?

No account fee, and a ten per cent discount on orders if the practitioner runs a no profit dispensary rather than taking a margin.

DHIS2: Can I buy commercial support?

Yes, from regional HISP groups or private implementers such as Devotta, which is contracted by HISP UiO for core platform development and also works independently.

Fullscript: Is there an enterprise option?

Yes, quoted for health systems, adding central catalogue control, API EHR integration and cross site reporting.

Share

Related pages

Other head to heads